{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T20:40:01Z","timestamp":1746909601737,"version":"3.40.5"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372312"],"award-info":[{"award-number":["82372312"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"DOI":"10.1007\/s00431-025-06109-5","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T06:25:48Z","timestamp":1743747948000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A novel conditioning regimen involving haploid immune cell infusion combined with umbilical cord blood transplantation for the treatment of juvenile myelomonocytic leukemia"],"prefix":"10.1007","volume":"184","author":[{"given":"Tianqi","family":"Liang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunfu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuelin","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sa","family":"Zong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haoran","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanru","family":"Pei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Yue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuming","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyong","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,2]]},"reference":[{"issue":"5","key":"6109_CR1","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","volume":"114","author":"JW Vardiman","year":"2009","unstructured":"Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A et al (2009) The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 114(5):937\u2013951","journal-title":"Blood"},{"issue":"20","key":"6109_CR2","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM et al (2016) The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127(20):2391\u20132405","journal-title":"Blood"},{"issue":"11","key":"6109_CR3","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1182\/blood.2022015850","volume":"140","author":"DA Arber","year":"2022","unstructured":"Arber DA, Orazi A, Hasserjian RP, Borowitz MJ, Calvo KR, Kvasnicka HM et al (2022) International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data. Blood 140(11):1200\u20131228","journal-title":"Blood"},{"issue":"10","key":"6109_CR4","first-page":"3534","volume":"89","author":"CM Niemeyer","year":"1997","unstructured":"Niemeyer CM, Arico M, Basso G, Biondi A, Cantu Rajnoldi A, Creutzig U et al (1997) Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. European working group on myelodysplastic syndromes in childhood (EWOG-MDS). Blood 89(10):3534\u201343","journal-title":"Blood"},{"issue":"1","key":"6109_CR5","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1182\/blood-2004-05-1944","volume":"105","author":"F Locatelli","year":"2005","unstructured":"Locatelli F, Nollke P, Zecca M, Korthof E, Lanino E, Peters C et al (2005) Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS\/EBMT trial. Blood 105(1):410\u2013419","journal-title":"Blood"},{"issue":"2","key":"6109_CR6","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1007\/s12185-014-1715-7","volume":"101","author":"M Yabe","year":"2015","unstructured":"Yabe M, Ohtsuka Y, Watanabe K, Inagaki J, Yoshida N, Sakashita K et al (2015) Transplantation for juvenile myelomonocytic leukemia: a retrospective study of 30 children treated with a regimen of busulfan, fludarabine, and melphalan. Int J Hematol 101(2):184\u2013190","journal-title":"Int J Hematol"},{"issue":"5","key":"6109_CR7","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.bbmt.2019.11.029","volume":"26","author":"N Yoshida","year":"2020","unstructured":"Yoshida N, Sakaguchi H, Yabe M, Hasegawa D, Hama A, Hasegawa D et al (2020) Clinical outcomes after allogeneic hematopoietic stem cell transplantation in children with juvenile myelomonocytic leukemia: a report from the Japan society for hematopoietic cell transplantation. Biol Blood Marrow Transplant 26(5):902\u2013910","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"6109_CR8","first-page":"2908","volume":"109","author":"D Meyran","year":"2024","unstructured":"Meyran D, Arfeuille C, Chevret S, Neven Q, Caye-Eude A, Lainey E et al (2024) A predictive classifier of poor prognosis in transplanted patients with juvenile myelomonocytic leukemia: a study on behalf of the Soci\u00e9t\u00e9 Francophone de Greffe de Moelle et de Th\u00e9rapie Cellulaire. Haematologica 109(9):2908\u20132919","journal-title":"Haematologica"},{"issue":"3","key":"6109_CR9","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1046\/j.0007-1048.2001.03333.x","volume":"116","author":"FO Smith","year":"2002","unstructured":"Smith FO, King R, Nelson G, Wagner JE, Robertson KA, Sanders JE et al (2002) Unrelated donor bone marrow transplantation for children with juvenile myelomonocytic leukaemia. Br J Haematol 116(3):716\u2013724","journal-title":"Br J Haematol"},{"issue":"2","key":"6109_CR10","doi-asserted-by":"publisher","first-page":"e13825","DOI":"10.1111\/petr.13825","volume":"25","author":"YC Lin","year":"2021","unstructured":"Lin YC, Luo CJ, Miao Y, Wang JM, Luo CY, Qin X et al (2021) Human leukocyte antigen disparities reduce relapse after hematopoietic stem cell transplantation in children with juvenile myelomonocytic leukemia: a single-center retrospective study from China. Pediatr Transplant 25(2):e13825","journal-title":"Pediatr Transplant"},{"issue":"5","key":"6109_CR11","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1111\/bjh.16107","volume":"190","author":"M Gabelli","year":"2020","unstructured":"Gabelli M, Veys P, Chiesa R (2020) Current status of umbilical cord blood transplantation in children. Br J Haematol 190(5):650\u2013683","journal-title":"Br J Haematol"},{"issue":"10","key":"6109_CR12","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.humimm.2022.03.001","volume":"83","author":"PY Arnold","year":"2022","unstructured":"Arnold PY (2022) Review: HLA loss and detection in the setting of relapse from HLA-mismatched hematopoietic cell transplant. Hum Immunol 83(10):712\u2013720","journal-title":"Hum Immunol"},{"key":"6109_CR13","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.canlet.2018.08.030","volume":"438","author":"Y Wang","year":"2018","unstructured":"Wang Y, Chen H, Chen J, Han M, Hu J, Jiong H et al (2018) The consensus on the monitoring, treatment, and prevention of leukemia relapse after allogeneic hematopoietic stem cell transplantation in China. Cancer Lett 438:63\u201375","journal-title":"Cancer Lett"},{"issue":"1","key":"6109_CR14","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41409-023-02137-7","volume":"59","author":"L Yang","year":"2024","unstructured":"Yang L, Lai X, Yang T, Lu Y, Liu L, Shi J et al (2024) Prophylactic versus preemptive modified donor lymphocyte infusion for high-risk acute leukemia after allogeneic hematopoietic stem cell transplantation: a multicenter retrospective study. Bone Marrow Transplant 59(1):85\u201392","journal-title":"Bone Marrow Transplant"},{"issue":"Supplement_1","key":"6109_CR15","doi-asserted-by":"publisher","first-page":"4181","DOI":"10.1182\/blood-2019-128331","volume":"134","author":"Z Peng","year":"2019","unstructured":"Peng Z, Feng X, Liu H, Liao J, Bu C, He Y et al (2019) Complementary transplantation with unrelated cord blood following haploidentical stem cells for juvenile myelomonocytic leukemia: double-centers study from China. Blood. 134(Supplement_1):4181","journal-title":"Blood."},{"key":"6109_CR16","doi-asserted-by":"publisher","first-page":"1426640","DOI":"10.3389\/fimmu.2024.1426640","volume":"15","author":"Z Peng","year":"2024","unstructured":"Peng Z, Gao J, Huang L, He Y, Tang H, Zong S, Pei Y, Pei F, Ge J, Liu X, Yue L, Zhou J, Li X, Yue D, Chen Y, Chen C, Wu X, Feng X, Li C (2024) Decitabine-based treatment strategy improved the outcome of HSCT in JMML: a retrospective cohort study. Front Immunol 15:1426640","journal-title":"Front Immunol"},{"issue":"12","key":"6109_CR17","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1182\/blood-2013-03-491589","volume":"122","author":"F Locatelli","year":"2013","unstructured":"Locatelli F, Crotta A, Ruggeri A, Eapen M, Wagner JE, Macmillan ML et al (2013) Analysis of risk factors influencing outcomes after cord blood transplantation in children with juvenile myelomonocytic leukemia: a EUROCORD, EBMT, EWOG-MDS.\u00a0CIBMTR study. Blood 122(12):2135\u20132141","journal-title":"Blood"},{"issue":"1","key":"6109_CR18","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3324\/haematol.2014.109892","volume":"100","author":"CM Niemeyer","year":"2015","unstructured":"Niemeyer CM, Loh ML, Cseh A, Cooper T, Dvorak CC, Chan R et al (2015) Criteria for evaluating response and outcome in clinical trials for children with juvenile myelomonocytic leukemia. Haematologica 100(1):17\u201322","journal-title":"Haematologica"},{"issue":"6","key":"6109_CR19","first-page":"825","volume":"15","author":"D Przepiorka","year":"1995","unstructured":"Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J et al (1995) 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 15(6):825\u20138","journal-title":"Bone Marrow Transplant"},{"key":"6109_CR20","doi-asserted-by":"crossref","unstructured":"Jagasia MH, Greinix HT, Arora M, Williams KM, Wolff D, Cowen EW, et al (2015) National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 Diagnosis and Staging Working Group report. Biol Blood Marrow Transplant 21(3):389-401e1","DOI":"10.1016\/j.bbmt.2014.12.001"},{"issue":"4","key":"6109_CR21","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1111\/bjh.12558","volume":"163","author":"FL Dignan","year":"2013","unstructured":"Dignan FL, Wynn RF, Hadzic N, Karani J, Quaglia A, Pagliuca A et al (2013) BCSH\/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation. Br J Haematol 163(4):444\u2013457","journal-title":"Br J Haematol"},{"issue":"1","key":"6109_CR22","first-page":"12","volume":"73","author":"S Cesaro","year":"2018","unstructured":"Cesaro S, Dalianis T, Hanssen Rinaldo C, Koskenvuo M, Pegoraro A, Einsele H et al (2018) ECIL guidelines for the prevention, diagnosis and treatment of BK polyomavirus-associated haemorrhagic cystitis in haematopoietic stem cell transplant recipients. J Antimicrob Chemother 73(1):12\u201321","journal-title":"J Antimicrob Chemother"},{"key":"6109_CR23","doi-asserted-by":"crossref","unstructured":"Martin PJ, Lee SJ, Przepiorka D, Horowitz MM, Koreth J, Vogelsang GB, et al (2015) National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: VI. The 2014 Clinical trial design working group report. Biol Blood Marrow Transplant 21(8):1343\u201359","DOI":"10.1016\/j.bbmt.2015.05.004"},{"key":"6109_CR24","doi-asserted-by":"crossref","unstructured":"Mayerhofer C, Niemeyer CM, Flotho C (2021) Current treatment of juvenile myelomonocytic leukemia. J Clin Med 10(14)","DOI":"10.3390\/jcm10143084"},{"issue":"2","key":"6109_CR25","first-page":"434","volume":"20","author":"WG Woods","year":"2002","unstructured":"Woods WG, Barnard DR, Alonzo TA, Buckley JD, Kobrinsky N, Arthur DC et al (2002) Prospective study of 90 children requiring treatment for juvenile myelomonocytic leukemia or myelodysplastic syndrome: a report from the Children\u2019s Cancer Group. J Clin Oncol 20(2):434\u2013440","journal-title":"J Clin Oncol"},{"issue":"7","key":"6109_CR26","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1182\/blood-2014-08-550483","volume":"125","author":"F Locatelli","year":"2015","unstructured":"Locatelli F, Niemeyer CM (2015) How I treat juvenile myelomonocytic leukemia. Blood 125(7):1083\u20131090","journal-title":"Blood"},{"issue":"4","key":"6109_CR27","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1200\/JCO.1994.12.4.671","volume":"12","author":"E Estey","year":"1994","unstructured":"Estey E, Thall P, Andreeff M, Beran M, Kantarjian H, O\u2019Brien S et al (1994) Use of granulocyte colony-stimulating factor before, during, and after fludarabine plus cytarabine induction therapy of newly diagnosed acute myelogenous leukemia or myelodysplastic syndromes: comparison with fludarabine plus cytarabine without granulocyte colony-stimulating factor. J Clin Oncol 12(4):671\u2013678","journal-title":"J Clin Oncol"},{"issue":"36","key":"6109_CR28","doi-asserted-by":"publisher","first-page":"4249","DOI":"10.1200\/JCO.19.03277","volume":"38","author":"L Gao","year":"2020","unstructured":"Gao L, Zhang Y, Wang S, Kong P, Su Y, Hu J et al (2020) Effect of rhG-CSF combined with decitabine prophylaxis on relapse of patients with high-risk MRD-negative AML after HSCT: an open-label, multicenter, randomized controlled trial. J Clin Oncol 38(36):4249\u20134259","journal-title":"J Clin Oncol"},{"issue":"2","key":"6109_CR29","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/17474086.2018.1421937","volume":"11","author":"F Locatelli","year":"2018","unstructured":"Locatelli F, Algeri M, Merli P, Strocchio L (2018) Novel approaches to diagnosis and treatment of Juvenile Myelomonocytic Leukemia. Expert Rev Hematol 11(2):129\u2013143","journal-title":"Expert Rev Hematol"},{"issue":"4","key":"6109_CR30","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1182\/blood.V62.4.737.737","volume":"62","author":"DA Carson","year":"1983","unstructured":"Carson DA, Wasson DB, Taetle R, Yu A (1983) Specific toxicity of 2-chlorodeoxyadenosine toward resting and proliferating human lymphocytes. Blood 62(4):737\u2013743","journal-title":"Blood"},{"issue":"10","key":"6109_CR31","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1182\/blood.V78.10.2583.2583","volume":"78","author":"AL Petzer","year":"1991","unstructured":"Petzer AL, Bilgeri R, Zilian U, Haun M, Geisen FH, Pragnell I et al (1991) Inhibitory effect of 2-chlorodeoxyadenosine on granulocytic, erythroid, and T-lymphocytic colony growth. Blood 78(10):2583\u20132587","journal-title":"Blood"},{"issue":"2","key":"6109_CR32","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S0006-2952(02)01486-7","volume":"65","author":"D Wyczechowska","year":"2003","unstructured":"Wyczechowska D, Fabianowska-Majewska K (2003) The effects of cladribine and fludarabine on DNA methylation in K562 cells. Biochem Pharmacol 65(2):219\u2013225","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"6109_CR33","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.exphem.2015.02.001","volume":"43","author":"BC Valdez","year":"2015","unstructured":"Valdez BC, Li Y, Murray D, Ji J, Liu Y, Popat U et al (2015) Comparison of the cytotoxicity of cladribine and clofarabine when combined with fludarabine and busulfan in AML cells: enhancement of cytotoxicity with epigenetic modulators. Exp Hematol 43(6):448-61e2","journal-title":"Exp Hematol"},{"issue":"10","key":"6109_CR34","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1002\/ijc.34419","volume":"152","author":"X Tong","year":"2023","unstructured":"Tong X, Li M, Jin J, Li Y, Li L, Peng Y et al (2023) Cladribine- and decitabine-containing conditioning regimen has a low post-transplant relapse rate in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome. Int J Cancer 152(10):2123\u20132133","journal-title":"Int J Cancer"},{"issue":"26","key":"6109_CR35","doi-asserted-by":"publisher","first-page":"3350","DOI":"10.1182\/blood-2015-12-629089","volume":"127","author":"C Sun","year":"2016","unstructured":"Sun C, Dotti G, Savoldo B (2016) Utilizing cell-based therapeutics to overcome immune evasion in hematologic malignancies. Blood 127(26):3350\u20133359","journal-title":"Blood"},{"key":"6109_CR36","doi-asserted-by":"publisher","first-page":"1328858","DOI":"10.3389\/fimmu.2024.1328858","volume":"15","author":"K Maurer","year":"2024","unstructured":"Maurer K, Antin JH (2024) The graft versus leukemia effect: donor lymphocyte infusions and cellular therapy. Front Immunol 15:1328858","journal-title":"Front Immunol"},{"issue":"4","key":"6109_CR37","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.bbmt.2008.12.503","volume":"15","author":"GA Colvin","year":"2009","unstructured":"Colvin GA, Berz D, Ramanathan M, Winer ES, Fast L, Elfenbein GJ et al (2009) Nonengraftment haploidentical cellular immunotherapy for refractory malignancies: tumor responses without chimerism. Biol Blood Marrow Transplant 15(4):421\u2013431","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"6109_CR38","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/pbc.24259","volume":"60","author":"J Inagaki","year":"2013","unstructured":"Inagaki J, Fukano R, Nishikawa T, Nakashima K, Sawa D, Ito N et al (2013) Outcomes of immunological interventions for mixed chimerism following allogeneic stem cell transplantation in children with juvenile myelomonocytic leukemia. Pediatr Blood Cancer 60(1):116\u2013120","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"6109_CR39","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/sj.leu.2403721","volume":"19","author":"A Yoshimi","year":"2005","unstructured":"Yoshimi A, Bader P, Matthes-Martin S, Stary J, Sedlacek P, Duffner U et al (2005) Donor leukocyte infusion after hematopoietic stem cell transplantation in patients with juvenile myelomonocytic leukemia. Leukemia 19(6):971\u2013977","journal-title":"Leukemia"},{"issue":"3","key":"6109_CR40","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1097\/00043426-200403000-00009","volume":"26","author":"YH Chang","year":"2004","unstructured":"Chang YH, Jou ST, Lin DT, Lu MY, Lin KH (2004) Second allogeneic hematopoietic stem cell transplantation for juvenile myelomonocytic leukemia: case report and literature review. J Pediatr Hematol Oncol 26(3):190\u2013193","journal-title":"J Pediatr Hematol Oncol"},{"issue":"3","key":"6109_CR41","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/sj.leu.2404537","volume":"21","author":"A Yoshimi","year":"2007","unstructured":"Yoshimi A, Mohamed M, Bierings M, Urban C, Korthof E, Zecca M et al (2007) Second allogeneic hematopoietic stem cell transplantation (HSCT) results in outcome similar to that of first HSCT for patients with juvenile myelomonocytic leukemia. Leukemia 21(3):556\u2013560","journal-title":"Leukemia"},{"issue":"Suppl 2","key":"6109_CR42","doi-asserted-by":"publisher","first-page":"S62","DOI":"10.1002\/sctm.20-0495","volume":"10","author":"X Zhu","year":"2021","unstructured":"Zhu X, Tang B, Sun Z (2021) Umbilical cord blood transplantation: still growing and improving. Stem Cells Transl Med. 10(Suppl 2):S62\u2013S74","journal-title":"Stem Cells Transl Med."},{"issue":"1","key":"6109_CR43","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.bbmt.2013.10.017","volume":"20","author":"H Zhou","year":"2014","unstructured":"Zhou H, Bao X, Wu X, Tang X, Wang M, Wu D et al (2014) Donor selection for killer immunoglobulin-like receptors B haplotype of the centromeric motifs can improve the outcome after HLA-identical sibling hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 20(1):98\u2013105","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"6109_CR44","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1038\/s41409-019-0543-z","volume":"54","author":"F Babor","year":"2019","unstructured":"Babor F, Peters C, Manser AR, Glogova E, Sauer M, Potschger U et al (2019) Presence of centromeric but absence of telomeric group B KIR haplotypes in stem cell donors improve leukaemia control after HSCT for childhood ALL. Bone Marrow Transplant 54(11):1847\u20131858","journal-title":"Bone Marrow Transplant"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-025-06109-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-025-06109-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-025-06109-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T20:03:06Z","timestamp":1746907386000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-025-06109-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,2]]},"references-count":44,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["6109"],"URL":"https:\/\/doi.org\/10.1007\/s00431-025-06109-5","relation":{},"ISSN":["1432-1076"],"issn-type":[{"type":"electronic","value":"1432-1076"}],"subject":[],"published":{"date-parts":[[2025,4,2]]},"assertion":[{"value":"22 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"274"}}